Hypoallergenicity and Effects on Growth and Tolerance of a New Amino Acid-Based Formula with Docosahexaenoic Acid and Arachidonic Acid

Objective In study 1, to compare the effect on growth in healthy infants of a new amino acid–based formula (AAF) and a control extensively hydrolyzed formula (EHF), with both docosahexaenoic acid (DHA) and arachidonic acid (ARA) at levels similar to those in human milk worldwide. In study 2, to eval...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pediatrics 2008-08, Vol.153 (2), p.266-271
Hauptverfasser: Burks, Wesley, MD, Jones, Stacie M., MD, Berseth, Carol Lynn, MD, Harris, Cheryl, MS, Sampson, Hugh A., MD, Scalabrin, Deolinda M.F., MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 271
container_issue 2
container_start_page 266
container_title The Journal of pediatrics
container_volume 153
creator Burks, Wesley, MD
Jones, Stacie M., MD
Berseth, Carol Lynn, MD
Harris, Cheryl, MS
Sampson, Hugh A., MD
Scalabrin, Deolinda M.F., MD, PhD
description Objective In study 1, to compare the effect on growth in healthy infants of a new amino acid–based formula (AAF) and a control extensively hydrolyzed formula (EHF), with both docosahexaenoic acid (DHA) and arachidonic acid (ARA) at levels similar to those in human milk worldwide. In study 2, to evaluate the hypoallergenicity of this new AAF in infants and children with confirmed cow's milk allergy (CMA). Study design In study 1, a total of 165 healthy, full-term, formula-fed infants randomly received the new AAF or control formula. Anthropometric measurements, tolerance, and adverse events were recorded throughout the study. Plasma amino acid profiles were evaluated in a subset of the infants. In study 2, the hypoallergenicity of the new AAF was evaluated in 32 infants and children using a double-blind, placebo-controlled food challenge; an open challenge; and a 7-day feeding. Results In study 1, overall growth, tolerance, and safety outcomes were similar in both groups. In study 2, 29 of the 32 subjects completed both challenges; no allergic reaction was seen in any of the 32 subjects. Conclusions The new AAF with DHA and ARA at levels similar to those in human milk worldwide is hypoallergenic. It also is safe and supports growth in healthy, term infants.
doi_str_mv 10.1016/j.jpeds.2008.02.043
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69339900</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022347608001753</els_id><sourcerecordid>69339900</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-e01b2bfaa496124d902429d9e466a2e19eb9933583d088cad03f8cf317db13503</originalsourceid><addsrcrecordid>eNqFksuO0zAUhiMEYjoDT4CEvIFdwvElabwAqQxzQRrBgmFtOfYJdUjjYjeUvsA8N04bgcSGlaWj7_9lfedk2QsKBQVavemKbos2FgygLoAVIPijbEFBLvOq5vxxtgBgLOdiWZ1l5zF2ACAFwNPsjNYlF4zDInu4PWy97nsM33Bwxu0ORA-WXLUtml0kfiA3we936-P03idODwaJb4kmn3BPVhs3eLIyzubvdURLrn3YjL0me5dCH7zxUa_xl8bBO3Pkjk2roM3aWT_Mw2fZk1b3EZ_P70X29frq_vI2v_t88_FydZcbIdguR6ANa1qthawoE1YCE0xaiaKqNEMqsZGS87LmFuraaAu8rU3L6dI2lJfAL7LXp95t8D9GjDu1cdFg3-sB_RhVldJSwgTyE2iCjzFgq7bBbXQ4KApq0q86ddSvJv0KmEr6U-rlXD82G7R_M7PvBLyaAR2N7tvJpot_OAZlSUtBE_f2xGGS8dNhUNE4TOatC2kxynr3n4-8-ydvepdk6_47HjB2fgxD8qyoiimgvkyXMh0K1AB0WXL-G_SzuNw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69339900</pqid></control><display><type>article</type><title>Hypoallergenicity and Effects on Growth and Tolerance of a New Amino Acid-Based Formula with Docosahexaenoic Acid and Arachidonic Acid</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Burks, Wesley, MD ; Jones, Stacie M., MD ; Berseth, Carol Lynn, MD ; Harris, Cheryl, MS ; Sampson, Hugh A., MD ; Scalabrin, Deolinda M.F., MD, PhD</creator><creatorcontrib>Burks, Wesley, MD ; Jones, Stacie M., MD ; Berseth, Carol Lynn, MD ; Harris, Cheryl, MS ; Sampson, Hugh A., MD ; Scalabrin, Deolinda M.F., MD, PhD</creatorcontrib><description>Objective In study 1, to compare the effect on growth in healthy infants of a new amino acid–based formula (AAF) and a control extensively hydrolyzed formula (EHF), with both docosahexaenoic acid (DHA) and arachidonic acid (ARA) at levels similar to those in human milk worldwide. In study 2, to evaluate the hypoallergenicity of this new AAF in infants and children with confirmed cow's milk allergy (CMA). Study design In study 1, a total of 165 healthy, full-term, formula-fed infants randomly received the new AAF or control formula. Anthropometric measurements, tolerance, and adverse events were recorded throughout the study. Plasma amino acid profiles were evaluated in a subset of the infants. In study 2, the hypoallergenicity of the new AAF was evaluated in 32 infants and children using a double-blind, placebo-controlled food challenge; an open challenge; and a 7-day feeding. Results In study 1, overall growth, tolerance, and safety outcomes were similar in both groups. In study 2, 29 of the 32 subjects completed both challenges; no allergic reaction was seen in any of the 32 subjects. Conclusions The new AAF with DHA and ARA at levels similar to those in human milk worldwide is hypoallergenic. It also is safe and supports growth in healthy, term infants.</description><identifier>ISSN: 0022-3476</identifier><identifier>EISSN: 1097-6833</identifier><identifier>DOI: 10.1016/j.jpeds.2008.02.043</identifier><identifier>PMID: 18534230</identifier><identifier>CODEN: JOPDAB</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Amino Acids - administration &amp; dosage ; Animals ; Arachidonic Acid - administration &amp; dosage ; Biological and medical sciences ; Child ; Child, Preschool ; Dietary Supplements ; Docosahexaenoic Acids - administration &amp; dosage ; Double-Blind Method ; Female ; General aspects ; Growth - drug effects ; Humans ; Infant ; Infant Food - adverse effects ; Infant Formula - administration &amp; dosage ; Infant, Newborn ; Male ; Medical sciences ; Milk - adverse effects ; Milk Hypersensitivity - diet therapy ; Milk Hypersensitivity - etiology ; Pediatrics ; Prospective Studies ; Treatment Outcome</subject><ispartof>The Journal of pediatrics, 2008-08, Vol.153 (2), p.266-271</ispartof><rights>Mosby, Inc.</rights><rights>2008 Mosby, Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-e01b2bfaa496124d902429d9e466a2e19eb9933583d088cad03f8cf317db13503</citedby><cites>FETCH-LOGICAL-c442t-e01b2bfaa496124d902429d9e466a2e19eb9933583d088cad03f8cf317db13503</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jpeds.2008.02.043$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20551541$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18534230$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Burks, Wesley, MD</creatorcontrib><creatorcontrib>Jones, Stacie M., MD</creatorcontrib><creatorcontrib>Berseth, Carol Lynn, MD</creatorcontrib><creatorcontrib>Harris, Cheryl, MS</creatorcontrib><creatorcontrib>Sampson, Hugh A., MD</creatorcontrib><creatorcontrib>Scalabrin, Deolinda M.F., MD, PhD</creatorcontrib><title>Hypoallergenicity and Effects on Growth and Tolerance of a New Amino Acid-Based Formula with Docosahexaenoic Acid and Arachidonic Acid</title><title>The Journal of pediatrics</title><addtitle>J Pediatr</addtitle><description>Objective In study 1, to compare the effect on growth in healthy infants of a new amino acid–based formula (AAF) and a control extensively hydrolyzed formula (EHF), with both docosahexaenoic acid (DHA) and arachidonic acid (ARA) at levels similar to those in human milk worldwide. In study 2, to evaluate the hypoallergenicity of this new AAF in infants and children with confirmed cow's milk allergy (CMA). Study design In study 1, a total of 165 healthy, full-term, formula-fed infants randomly received the new AAF or control formula. Anthropometric measurements, tolerance, and adverse events were recorded throughout the study. Plasma amino acid profiles were evaluated in a subset of the infants. In study 2, the hypoallergenicity of the new AAF was evaluated in 32 infants and children using a double-blind, placebo-controlled food challenge; an open challenge; and a 7-day feeding. Results In study 1, overall growth, tolerance, and safety outcomes were similar in both groups. In study 2, 29 of the 32 subjects completed both challenges; no allergic reaction was seen in any of the 32 subjects. Conclusions The new AAF with DHA and ARA at levels similar to those in human milk worldwide is hypoallergenic. It also is safe and supports growth in healthy, term infants.</description><subject>Amino Acids - administration &amp; dosage</subject><subject>Animals</subject><subject>Arachidonic Acid - administration &amp; dosage</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Dietary Supplements</subject><subject>Docosahexaenoic Acids - administration &amp; dosage</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>General aspects</subject><subject>Growth - drug effects</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant Food - adverse effects</subject><subject>Infant Formula - administration &amp; dosage</subject><subject>Infant, Newborn</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Milk - adverse effects</subject><subject>Milk Hypersensitivity - diet therapy</subject><subject>Milk Hypersensitivity - etiology</subject><subject>Pediatrics</subject><subject>Prospective Studies</subject><subject>Treatment Outcome</subject><issn>0022-3476</issn><issn>1097-6833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFksuO0zAUhiMEYjoDT4CEvIFdwvElabwAqQxzQRrBgmFtOfYJdUjjYjeUvsA8N04bgcSGlaWj7_9lfedk2QsKBQVavemKbos2FgygLoAVIPijbEFBLvOq5vxxtgBgLOdiWZ1l5zF2ACAFwNPsjNYlF4zDInu4PWy97nsM33Bwxu0ORA-WXLUtml0kfiA3we936-P03idODwaJb4kmn3BPVhs3eLIyzubvdURLrn3YjL0me5dCH7zxUa_xl8bBO3Pkjk2roM3aWT_Mw2fZk1b3EZ_P70X29frq_vI2v_t88_FydZcbIdguR6ANa1qthawoE1YCE0xaiaKqNEMqsZGS87LmFuraaAu8rU3L6dI2lJfAL7LXp95t8D9GjDu1cdFg3-sB_RhVldJSwgTyE2iCjzFgq7bBbXQ4KApq0q86ddSvJv0KmEr6U-rlXD82G7R_M7PvBLyaAR2N7tvJpot_OAZlSUtBE_f2xGGS8dNhUNE4TOatC2kxynr3n4-8-ydvepdk6_47HjB2fgxD8qyoiimgvkyXMh0K1AB0WXL-G_SzuNw</recordid><startdate>20080801</startdate><enddate>20080801</enddate><creator>Burks, Wesley, MD</creator><creator>Jones, Stacie M., MD</creator><creator>Berseth, Carol Lynn, MD</creator><creator>Harris, Cheryl, MS</creator><creator>Sampson, Hugh A., MD</creator><creator>Scalabrin, Deolinda M.F., MD, PhD</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080801</creationdate><title>Hypoallergenicity and Effects on Growth and Tolerance of a New Amino Acid-Based Formula with Docosahexaenoic Acid and Arachidonic Acid</title><author>Burks, Wesley, MD ; Jones, Stacie M., MD ; Berseth, Carol Lynn, MD ; Harris, Cheryl, MS ; Sampson, Hugh A., MD ; Scalabrin, Deolinda M.F., MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-e01b2bfaa496124d902429d9e466a2e19eb9933583d088cad03f8cf317db13503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Amino Acids - administration &amp; dosage</topic><topic>Animals</topic><topic>Arachidonic Acid - administration &amp; dosage</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Dietary Supplements</topic><topic>Docosahexaenoic Acids - administration &amp; dosage</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>General aspects</topic><topic>Growth - drug effects</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant Food - adverse effects</topic><topic>Infant Formula - administration &amp; dosage</topic><topic>Infant, Newborn</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Milk - adverse effects</topic><topic>Milk Hypersensitivity - diet therapy</topic><topic>Milk Hypersensitivity - etiology</topic><topic>Pediatrics</topic><topic>Prospective Studies</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burks, Wesley, MD</creatorcontrib><creatorcontrib>Jones, Stacie M., MD</creatorcontrib><creatorcontrib>Berseth, Carol Lynn, MD</creatorcontrib><creatorcontrib>Harris, Cheryl, MS</creatorcontrib><creatorcontrib>Sampson, Hugh A., MD</creatorcontrib><creatorcontrib>Scalabrin, Deolinda M.F., MD, PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burks, Wesley, MD</au><au>Jones, Stacie M., MD</au><au>Berseth, Carol Lynn, MD</au><au>Harris, Cheryl, MS</au><au>Sampson, Hugh A., MD</au><au>Scalabrin, Deolinda M.F., MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypoallergenicity and Effects on Growth and Tolerance of a New Amino Acid-Based Formula with Docosahexaenoic Acid and Arachidonic Acid</atitle><jtitle>The Journal of pediatrics</jtitle><addtitle>J Pediatr</addtitle><date>2008-08-01</date><risdate>2008</risdate><volume>153</volume><issue>2</issue><spage>266</spage><epage>271</epage><pages>266-271</pages><issn>0022-3476</issn><eissn>1097-6833</eissn><coden>JOPDAB</coden><abstract>Objective In study 1, to compare the effect on growth in healthy infants of a new amino acid–based formula (AAF) and a control extensively hydrolyzed formula (EHF), with both docosahexaenoic acid (DHA) and arachidonic acid (ARA) at levels similar to those in human milk worldwide. In study 2, to evaluate the hypoallergenicity of this new AAF in infants and children with confirmed cow's milk allergy (CMA). Study design In study 1, a total of 165 healthy, full-term, formula-fed infants randomly received the new AAF or control formula. Anthropometric measurements, tolerance, and adverse events were recorded throughout the study. Plasma amino acid profiles were evaluated in a subset of the infants. In study 2, the hypoallergenicity of the new AAF was evaluated in 32 infants and children using a double-blind, placebo-controlled food challenge; an open challenge; and a 7-day feeding. Results In study 1, overall growth, tolerance, and safety outcomes were similar in both groups. In study 2, 29 of the 32 subjects completed both challenges; no allergic reaction was seen in any of the 32 subjects. Conclusions The new AAF with DHA and ARA at levels similar to those in human milk worldwide is hypoallergenic. It also is safe and supports growth in healthy, term infants.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>18534230</pmid><doi>10.1016/j.jpeds.2008.02.043</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3476
ispartof The Journal of pediatrics, 2008-08, Vol.153 (2), p.266-271
issn 0022-3476
1097-6833
language eng
recordid cdi_proquest_miscellaneous_69339900
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Amino Acids - administration & dosage
Animals
Arachidonic Acid - administration & dosage
Biological and medical sciences
Child
Child, Preschool
Dietary Supplements
Docosahexaenoic Acids - administration & dosage
Double-Blind Method
Female
General aspects
Growth - drug effects
Humans
Infant
Infant Food - adverse effects
Infant Formula - administration & dosage
Infant, Newborn
Male
Medical sciences
Milk - adverse effects
Milk Hypersensitivity - diet therapy
Milk Hypersensitivity - etiology
Pediatrics
Prospective Studies
Treatment Outcome
title Hypoallergenicity and Effects on Growth and Tolerance of a New Amino Acid-Based Formula with Docosahexaenoic Acid and Arachidonic Acid
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T06%3A05%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypoallergenicity%20and%20Effects%20on%20Growth%20and%20Tolerance%20of%20a%20New%20Amino%20Acid-Based%20Formula%20with%20Docosahexaenoic%20Acid%20and%20Arachidonic%20Acid&rft.jtitle=The%20Journal%20of%20pediatrics&rft.au=Burks,%20Wesley,%20MD&rft.date=2008-08-01&rft.volume=153&rft.issue=2&rft.spage=266&rft.epage=271&rft.pages=266-271&rft.issn=0022-3476&rft.eissn=1097-6833&rft.coden=JOPDAB&rft_id=info:doi/10.1016/j.jpeds.2008.02.043&rft_dat=%3Cproquest_cross%3E69339900%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69339900&rft_id=info:pmid/18534230&rft_els_id=S0022347608001753&rfr_iscdi=true